Wearable ultrasonic Novosound is actively advancing ultrasound wearables with demonstrated blood pressure monitoring and wearable miniaturization, indicating strong cross-sell opportunities to consumer health tech manufacturers, athletic wear brands, and remote patient monitoring providers.

Medical partnerships Strategic collaboration with Texas Medical Center and focus on medical markets suggest openings for partnerships with hospitals, clinics, and research institutions seeking validated ultrasound sensing solutions and clinical use case development.

Funding momentum Recent £2M funding round from Par Equity, Kelvin Capital, University of the West of Scotland, and Scottish Enterprise signals investor confidence and potential for co-investment, enabling joint go-to-market initiatives and pilot programs with healthcare and medtech players.

Geographic growth Expansion of offices into Glasgow and Northern Europe creates regional deployment capabilities, presenting sales opportunities for European distributors, system integrators, and regional resellers targeting EU healthcare providers and medical device integrators.

executive leadership Appointment of Gary Beale as executive vice chairman strengthens market credibility and opens doors for high-level introductions to strategic customers, potential hospital networks, and enterprise buyers seeking scalable ultrasound sensor solutions.